Our studies have shown that prolactin produced in breast cancer cells through intracrine activation of PRLR and via at least two signal transduction pathways, JAK2/STAT5 and JAK2/PI3K/MEK/ERK, up-regulates the human prolactin receptor. This evidence concerns the gene PRLR and breast cancer.